Closing fall, fifteen firms gained initial licenses to develop clinical marijuana in Maryland, however the brand new business has since been mired in felony demanding situations. Erin Cox of the Baltimore Solar will get us up to the mark. Then, a large-scale find out about of a compound in hashish reveals it will possibly scale back seizures that don’t reply to conventional remedies. We talk to Dr. Orrin Devinsky, director of the Complete Epilepsy Middle at New York College Langone Clinical Middle. And Gail Rand, a mom, tells us how her son’s epilepsy caused her to change into an suggest for clinical hashish.
Previous July 1 release of Nevada's leisure pot gross sales in query
Next Hashish shoppers must come first in legalization debate
About the author